13438-30-7

Basic information

• Product Name: 5-nitroisophthaloyl chloride
• Synonyms: 5-Nitroisophthaloyl chloride; 5-nitrobenzene-1,3-dicarbonyl dichloride
• CAS NO: 13438-30-7
• Molecular Formula: C₈H₃Cl₂NO₄
• Molecular Weight: 248.0197
• EINECS: 236-575-1
• Mol File: 13438-30-7.mol
• Article Data: 73

Chemical Properties

• Boiling Point: 349.2°C at 760 mmHg
• Flash Point: 165°C
• Density: 1.609g/cm³
• Vapor Pressure: 4.78E-05mmHg at 25°C
• Refractive Index: 1.608
• CAS DataBase Reference: 5-nitroisophthaloyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 5-nitroisophthaloyl chloride(13438-30-7)
• EPA Substance Registry System: 5-nitroisophthaloyl chloride(13438-30-7)

Safety Data

• Hazardous Substances Data: 13438-30-7(Hazardous Substances Data)

Upstream product

• 79-37-8 oxalyl dichloride 
• 618-88-2 5-nitrobenzene-1,3-dicarboxylic acid 

Downstream Products

• 860556-59-8 1,3-dibenzoyl-5-nitro-benzene 
• 129648-68-6 1,3-bis<<(6-aminopyrid-2-yl)amino>carbonyl>-5-nitrobenzene 
• 118988-11-7 [2-(2-{2-[2-(Butyl-{3-[butyl-({2-[2-(2-ethoxycarbonylmethoxy-ethoxy)-ethoxy]-ethylcarbamoyl}-methyl)-carbamoyl]-5-nitro-benzoyl}-amino)-acetylamino]-ethoxy}-ethoxy)-ethoxy]-acetic acid ethyl ester 
• 157557-40-9 N,N'-Bis-[2-(3,4-dimethoxy-phenyl)-ethyl]-5-nitro-isophthalamide 
• 33224-18-9 5-nitrobenzene-1,3-dicarbonitrile 
• 263843-49-8 4-{3-[3-tert-butoxycarbonyl-1,1-bis-(2-tert-butoxycarbonyl-ethyl)-propylcarbamoyl]-5-nitro-benzoylamino}-4-(2-tert-butoxycarbonyl-ethyl)-heptanedioic acid di-tert-butyl ester 
• 441775-23-1 3,5-bis(4-methoxylbenzoyl)nitrobenzene 
• 349408-79-3 N,N'-dimethyl-5-nitro-isophthalamide 
• 1192881-59-6 bis((S)-2-(4-methoxybenzyloxy)-2-oxo-1-phenylethyl) 5-nitroisophthalate 
• 267898-29-3 C₂₀H₂₅NO₆ 
• 1211451-03-4 (2S,2S')-tetramethyl 2,2'-((5-nitroisophthaloyl)bis(azanediyl))disuccinate 
• 1299474-88-6 N,N'-bis[6-(2-ethylhexanoylamino)pyrid-2-yl]-5-nitroisophthalamide 
• 1299474-84-2 5-nitro-N,N'-bis[6-(pentanoylamino)pyrid-2-yl]isophthalamide 

Relevant articles and documents

Chirality Transfer from Chiral Monoamines to an m-Phthalic Diamide-Linked Zinc Bisporphyrinate with a Benzylamide Substituent

An m-phthalic diamide-linked bisporphyrin with a benzylamide substituent has been designed and synthesized. It has two types of carbonyl groups. In the solution of this zinc bisporphyrinate, these carbonyl groups are involved in the formation of two diffe

An amide hydrogen bond templated [1]rotaxane displaying a peptide motif-demonstrating an expedient route to synthetic mimics of lasso peptides

The rapid synthesis of an amide hydrogen bond templated [1]rotaxane is reported-demonstrating a potential pathway to synthetic analogues of lasso peptides. The structures of the [1]rotaxane and its unthreaded isomer have been characterized by NMR spectros

Alternative approach to an AB2 monomer for hyperbranched poly(arylene ether ketone imide)s

An alternative approach to an AB2 monomer, N-[3,5-bis(4-hydroxybenzoyl) benzene]-4-fluorophthalimde, 4, for hyperbranched poly(arylene ether ketone imide)s has been developed. The key steps were a para-position selective electrophilic aromatic substitutio

Convergent Ditopic Receptors Enhance Anion Binding upon Alkali Metal Complexation for Catalyzing the Ritter Reaction

A supramolecular approach to catalyzing the Ritter reaction by utilizing enhanced anion-binding affinity in the presence of alkali metal cations was developed with ditopic hydrogen-bonded amide macrocycles. With prebound cations in the macrocycle, particu

Cationic lipid molecule, and application thereof in nucleic acid delivery

The present invention discloses a cationic lipid molecule, and an application thereof in nucleic acid delivery. The structural formula of the cationic lipid molecule is represented by formula i. The invention further provides a cationic liposome, a lipid compound, a reagent, a kit, a preparation and a medicinal composition based on the cationic lipid molecule. The cationic lipid molecule has the advantages of simple synthesis process and good stability, and the cationic liposome has a high efficiency (characterized by high transfection efficiency) and a low toxicity, is stable and uniform, is easy to prepare, and can be used for transferring various cell lines. The cationic lipid molecule has excellent transitivity, and can efficiently deliver active substances (such as exemplary siRNA) omto cells (such as exemplary lung cancer cells), tissues and organs to achieve efficient regulation of the active substances. The problem that the toxicity and the transfer efficiency of cationic liposome existing in the prior art are low is solved.